Io Therapeutics, Inc. — Form D
Io Therapeutics, Inc. of SPRING, TX, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-02. The offering totals $1.0M, of which $444K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-01-02
- Form: D
- Accession: 0001538762-14-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $444K
- Remaining: $556K
- Investors: 4
- Date of first sale: 2013-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-209179
Issuer
- Name: Io Therapeutics, Inc.
- CIK: 0001538762
- Entity type: Corporation
- Jurisdiction: TEXAS
- Incorporated: 2010
- Address: 9450 PINECROFT DR., SUITE 9497, SPRING, TX, 77387
- Phone: 832-260-6201
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Roshantha A Chandraratna | Director | Santa Ana, CA |
| Martin E Sanders | Director | Santa Ana, CA |
| Scott A Thacher | Director | Santa Ana, CA |
| Roshantha A Chandraratna | Executive Officer | Santa Ana, CA |
| Martin E Sanders | Executive Officer | Santa Ana, CA |
| Sharon Lew | Executive Officer | SPRING, TX |
| Sahani Chandraratna | Director | SPRING, TX |
| Vidyasagar Vuligonda | Executive Officer | SPRING, TX |
| Martin Sanders | Executive Officer | SPRING, TX |
Other filings by this issuer (2)
More